Trial Profile
A Prospective, Multi-centre, Observational, Post-marketing study to evaluate the safety and efficacy of premixed insulin to insulin glargine with or without oral anti-diabetics in patients with Type II Diabetes mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2018
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 Aug 2018 New trial record
- 01 Aug 2018 Results published in the Diabetes Therapy